PT  - JOURNAL ARTICLE
AU  - Arifa S. Khan
AU  - Dominick A. Vacante
AU  - Jean-Pol Cassart
AU  - Siemon H. S. Ng
AU  - Christophe Lambert
AU  - Robert L. Charlebois
AU  - Kathryn E. King
TI  - Advanced Virus Detection Technologies Interest Group (AVDTIG): Efforts on High Throughput Sequencing (HTS) for Virus Detection
AID  - 10.5731/pdajpst.2016.007161
DP  - 2016 Nov 01
TA  - PDA Journal of Pharmaceutical Science and Technology
PG  - 591--595
VI  - 70
IP  - 6
4099  - http://journal.pda.org/content/70/6/591.short
4100  - http://journal.pda.org/content/70/6/591.full
SO  - PDA J Pharm Sci Technol2016 Nov 01; 70
AB  - Several nucleic-acid based technologies have recently emerged with capabilities for broad virus detection. One of these, high throughput sequencing, has the potential for novel virus detection because this method does not depend upon prior viral sequence knowledge. However, the use of high throughput sequencing for testing biologicals poses greater challenges as compared to other newly introduced tests due to its technical complexities and big data bioinformatics. Thus, the Advanced Virus Detection Technologies Users Group was formed as a joint effort by regulatory and industry scientists to facilitate discussions and provide a forum for sharing data and experiences using advanced new virus detection technologies, with a focus on high throughput sequencing technologies. The group was initiated as a task force that was coordinated by the Parenteral Drug Association and subsequently became the Advanced Virus Detection Technologies Interest Group to continue efforts for using new technologies for detection of adventitious viruses with broader participation, including international government agencies, academia, and technology service providers.